Best of ASCO® Toronto 2024: Canadian Achievements in Cancer Research – Dr. Natasha Leighl, Dr. Geoffrey Liu, Dr. Jennifer Knox
OR
Co-Chairs
Dr. Aly-Khan Lalani
Dr. Natasha Leighl
Speakers
Dr. Natasha Leighl
Dr. Geoffrey Liu
Dr. Jennifer Knox
Studies/trials discussed:
- PALOMA-3 Study
- Subcutaneous versus Intravenous Amivantamab, both in Combination with Lazertinib, in Refractory EGFR-mutated NSCLC: Primary Results from the Phase 3 PALOMA-3 Study
- CROWN Study
- Lorlatinib vs crizotinib in treatment-naïve patients with advanced ALK+ non-small cell lung cancer: 5-year progression-free survival and safety from the CROWN study
- PASS-01 Trial
- MARIPOSA Study
- COCOON Study
- PAPILLON trial
